12 results
8-K
EX-99.2
GOSS
Gossamer Bio Inc
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
-to-severe eosinophilic asthma A small minority are treated with approved biologic agents An additional ~1.5 million patients without elevated eosinophils
10-K
2018 FY
GOSS
Gossamer Bio Inc
22 Mar 19
Annual report
4:45pm
been limited to a minority of patients in only a small number of approved indications, and many cancers show little to no response to checkpoint … ;
no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;
the exclusive
S-1/A
7lrfvey vqphvc398he
23 Jan 19
IPO registration (amended)
4:39pm
424B4
x44wjvis6xxrs sx3gve
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1
eoug1wsg6vt4fcscvj
21 Dec 18
IPO registration
4:39pm
DRS/A
76bqlqr7i1pmxws3s5bp
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
rkgl91h
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next